Metabolite technology developed in the UArizona College of Medicine – Tucson has been licensed to MetFora, a startup launched through Tech Launch Arizona .

While the isolation and stress of the pandemic has affected overall mental health, Health Sciences experts say teenagers have been hit particularly hard.

The inaugural chest pain guideline from the American College of Cardiology/American Heart Association redefines how physicians discuss chest pain with patients and provides a detailed clinical decision pathway for diagnosis and management. Joseph S. Alpert, MD, a professor of medicine and cardiologist at the UArizona Sarver Heart Center and College of Medicine – Tucson, is quoted.

Researchers at the UArizona College of Medicine – Tucson have developed a new way to provide earlier diagnosis of lung disease. The method involves analyzing metabolites, small molecules that are produced through cellular metabolic reactions.

The UArizona Poison and Drug Information Center and Banner Poison Control Center have reported a significant increase in calls related to marijuana from health care professionals. Steven Dudley, PharmD, DABAT, a clinical toxicologist in the R. Ken Coit College of Pharmacy and director of the UArizona Poison and Drug Information Center, is quoted.

The All of Us Research Program UArizona-Banner will allow researchers to better address health disparities in underrepresented populations.

The legacy of racism in healthcare for Black patients in America has been a pressing issue that has an impact when someone goes in for critical care. Victoria Murrain, DO, vice dean of diversity, equity and inclusion at the College of Medicine – Tucson, discusses what the college is doing to build an environment where true diversity can thrive.

Victoria Maizes, MD, executive director of the Andrew Weil Center for Integrative Medicine at the University of Arizona, discusses the Centers for Disease Control and Prevention updated Clinical Practice Guideline for Prescribing Opioids.

The COVID-19 vaccine authorization for younger children was delayed as the FDA seeks to review new data. Saman Nematollahi, MD, assistant professor of medicine in the Division of Infectious Diseases at the College of Medicine – Tucson, is interviewed.